Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Chemotherapy vs Cisplatin and Gemcitabine as Adjuvant Treatment for Bladder Cancer
NCT00014534Phase 3Completed
- Sponsor
- Cancer and Leukemia Group B
- Start
- Mar 2004
- Primary completion
- Jul 2005
- Modality
- Targeted Liposomes, Cytokines & Interferons, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
A Phase 3 trial of pegylated liposomal doxorubicin, Paclitaxel Micelles for Injection in bladder cancer, sponsored by Cancer and Leukemia Group B. Started Mar 2004; status: completed.
02
Drugs
pegylated liposomal doxorubicinPaclitaxel Micelles for Injection
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00014534.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00014534.